The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CEA response and depth of response (DpR) to predict clinical outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with first-line cetuximab plus oxaliplatin-based chemotherapy: A sub-analysis of the JACCRO CC-05/06 trials.
 
Yu Sunakawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Yakult Honsha (Inst)
 
Wataru Ichikawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Merck Serono; Nippon Kayaku; Sawai Pharmaceutical Co; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Merck Serono; Ono Pharmaceutical; Zeria Pharmaceutical
Research Funding - Eisai; Taiho Pharmaceutical; Takeda
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Akihito Tsuji
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda
 
Tadamichi Denda
No Relationships to Disclose
 
Yoshihiko Segawa
Speakers' Bureau - Eisai; Mochida Pharmaceutical Co. Ltd.; Novartis; Taiho Pharmaceutical
Research Funding - AstraZeneca Japan (Inst); Bayer Yakuhin (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline K.K. (Inst); Parexel (Inst); Taiho Pharmaceutical (Inst)
 
Yuji Negoro
No Relationships to Disclose
 
Ken Shimada
No Relationships to Disclose
 
Mitsugu Kochi
No Relationships to Disclose
 
Masato Nakamura
Honoraria - Merck Serono; Taiho Pharmaceutical; Yakult Honsha
 
Masahito Kotaka
Honoraria - Chugai Pharma; Merck Serono; Takeda; Yakult Honsha
 
Hiroaki Tanioka
No Relationships to Disclose
 
Akinori Takagane
No Relationships to Disclose
 
Satoshi Tani
No Relationships to Disclose
 
Tatsuro Yamaguchi
No Relationships to Disclose
 
Masahiro Takeuchi
Honoraria - Mitsubishi Tanabe Pharma
Consulting or Advisory Role - Abbvie; AstraZeneca Japan; Hisamitsu Pharmaceutical; Kowa; Shionogi; Taiho Pharmaceutical
Travel, Accommodations, Expenses - AnGes
 
Masashi Fujii
Stock and Other Ownership Interests - Otsuka (I)
Consulting or Advisory Role - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Japan Clinical Cancer Research Organization
 
Toshifusa Nakajima
Honoraria - Taiho Pharmaceutical